1 | 98% dehydrated alcohol | - | - | - | - | 1件: 298 298 💬
|
2 | A04ad10 | - | - | - | - | 1件: 298 298 💬
|
3 | Acarbose | 1件: Acarbose Acarbose | 1件: Acarbose
Acarbose
💬
| 5件: AMY AMY, AMY, GAA, GANC, MGAM 💬
| 6件: Carbohydrate digestion and absorption Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬 | 1件: 298 298 💬
|
4 | Acetyl-L-carnitine 1000MG 2X PER DAY FOR 3 months | 1件: Acetylcarnitine Acetylcarnitine | - | - | - | 1件: 298 298 💬
|
5 | Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬
| - | - | 10件: 34 34, 51, 53, 85, 94, 97, 193, 233, 298, 299 💬
|
6 | Alanine | 1件: Alanine Alanine | 1件: Alanine
Alanine
💬
| - | - | 3件: 70 70, 94, 298 💬
|
7 | Alpha 1-antitrypsin | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | 1件: alpha 1-Antitrypsin
alpha 1-Antitrypsin
💬
| 1件: SERPINA1 SERPINA1 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 231 231, 298 💬
|
8 | Amino acids | 1件: Amino acids Amino acids | - | - | - | 4件: 6 6, 70, 90, 298 💬
|
9 | Amlodipine | 1件: Amlodipine Amlodipine | 4件: Amlodipine besylate
Amlodipine besylate
,
Amlodipine maleate
,
Amlodipine
,
Amlodipine benzoate
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 67 67, 298 💬
|
10 | Analgesics | - | - | - | - | 1件: 298 298 💬
|
11 | Antioxidant plus pregabalin | - | - | - | - | 1件: 298 298 💬
|
12 | Antioxidants | - | - | - | - | 3件: 90 90, 298, 310 💬
|
13 | Antox (vers) 1.2 | - | - | - | - | 1件: 298 298 💬
|
14 | Antox (vers.)1.2 | - | - | - | - | 1件: 298 298 💬
|
15 | Antox version 1.2 | - | - | - | - | 1件: 298 298 💬
|
16 | Ascorbic acid | 1件: Ascorbic acid Ascorbic acid | 1件: Ascorbic acid
Ascorbic acid
💬
| - | - | 4件: 10 10, 97, 206, 298 💬
|
17 | Autologous mesenchymal stromal cell | - | - | - | - | 2件: 96 96, 298 💬
|
18 | Bone marrow-derived mesenchymal stem cells | - | - | - | - | 1件: 298 298 💬
|
19 | Bupivicaine alone | - | - | - | - | 1件: 298 298 💬
|
20 | Buprenorphine | 1件: Buprenorphine Buprenorphine | 2件: Buprenorphine hydrochloride
Buprenorphine hydrochloride
,
Buprenorphine
💬
| 2件: OPRK1 OPRK1, OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 2件: 70 70, 298 💬
|
21 | Calcium, dietary | 1件: Calcium Calcium | - | - | - | 1件: 298 298 💬
|
22 | Carbon monoxide-bubbled mediums | 2件: Activated charcoal Activated charcoal, Carbon monoxide | 2件: Charcoal, activated
Charcoal, activated
,
Carbon monoxide
💬
| - | - | 1件: 298 298 💬
|
23 | Celiac block with triamcinolone and bupivicaine | - | - | - | - | 1件: 298 298 💬
|
24 | Cholecalciferol | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 9件: 13 13, 19, 34, 46, 49, 96, 97, 298, 299 💬
|
25 | Continuous glucose monitor | - | - | - | - | 2件: 65 65, 298 💬
|
26 | Creon | - | - | - | - | 2件: 298 298, 299 💬
|
27 | Creon 10000 | - | - | - | - | 2件: 298 298, 299 💬
|
28 | Creon 25000 | - | - | - | - | 2件: 298 298, 299 💬
|
29 | Diazepam | 1件: Diazepam Diazepam | 1件: Diazepam
Diazepam
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 155 155, 298 💬
|
30 | Dronabinol | 1件: Dronabinol Dronabinol | 1件: Dronabinol
Dronabinol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 3件: 2 2, 13, 298 💬
|
31 | Empagliflozin | 1件: Empagliflozin Empagliflozin | 1件: Empagliflozin
Empagliflozin
💬
| - | - | 10件: 65 65, 67, 72, 77, 86, 96, 97, 257, 298, 299 💬
|
32 | Endoscopic drainage OF THE main pancreatic duct | - | - | - | - | 1件: 298 298 💬
|
33 | Endoscopy FOR pancreatic function testing | - | - | - | - | 1件: 298 298 💬
|
34 | Ensure surgical | - | - | - | - | 1件: 298 298 💬
|
35 | Ercp with bupivacaine infusion | - | - | - | - | 1件: 298 298 💬
|
36 | Esomeprazole | 1件: Esomeprazole Esomeprazole | 5件: Esomeprazole magnesium
Esomeprazole magnesium
,
Esomeprazole sodium
,
Esomeprazole
,
Esomeprazole strontium
,
Esomeprazole magnesium dihydrate
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 9件: 6 6, 13, 46, 86, 98, 107, 113, 298, 299 💬
|
37 | Etanercept | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬
| 2件: LTA LTA, TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 15件: 15 15, 35, 38, 39, 46, 50, 53, 60, 85, 107, 228, 270, 271, 285, 298 💬
|
38 | EUR-1008 (APT-1008) high dose | - | - | - | - | 1件: 298 298 💬
|
39 | EUR-1008 (APT-1008) LOW dose | - | - | - | - | 1件: 298 298 💬
|
40 | EUR-1066-A | - | - | - | - | 1件: 298 298 💬
|
41 | EUR-1066-B | - | - | - | - | 1件: 298 298 💬
|
42 | EUS procedure with drug injection | - | - | - | - | 1件: 298 298 💬
|
43 | Extracorporeal shock wave lithotripsy | - | - | - | - | 1件: 298 298 💬
|
44 | Extracorporeal shock wave lithotripsy and endoscopic drainage OF THE main pancreatic duct | - | - | - | - | 1件: 298 298 💬
|
45 | Fentanyl | 1件: Fentanyl Fentanyl | 3件: Fentanyl
Fentanyl
,
Fentanyl citrate
,
Fentanyl hydrochloride
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 5件: 46 46, 70, 97, 231, 298 💬
|
46 | Fluimucil*20CPR EFF 600MG | - | - | - | - | 2件: 94 94, 298 💬
|
47 | Gabapentin prescriptions | 1件: Gabapentin Gabapentin | 1件: Gabapentin
Gabapentin
💬
| 5件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
| 10件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 1件: 298 298 💬
|
48 | Genetic sequencing | - | - | - | - | 3件: 40 40, 231, 298 💬
|
49 | Human secretin | 1件: Secretin human Secretin human | 1件: Secretin
Secretin
💬
| 1件: SCTR SCTR 💬
| 3件: Bile secretion Bile secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion 💬 | 1件: 298 298 💬
|
50 | Hydroxychloroquine | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 26件: 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
|
51 | Indomethacin | 1件: Indomethacin Indomethacin | 2件: Indomethacin
Indomethacin
,
Indomethacin sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 3件: 225 225, 271, 298 💬
|
52 | Intra plexus triamcinolone and bupivicaine injection | - | - | - | - | 1件: 298 298 💬
|
53 | Kreon 25000 | - | - | - | - | 2件: 298 298, 299 💬
|
54 | Laboratory biomarker analysis | - | - | - | - | 22件: 11 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
|
55 | Lacosamide | 1件: Lacosamide Lacosamide | 1件: Lacosamide
Lacosamide
💬
| 2件: SCN3A SCN3A, SCN9A 💬
| 1件: Taste transduction Taste transduction 💬 | 4件: 2 2, 46, 149, 298 💬
|
56 | Lanreotide acetate | 1件: Lanreotide Lanreotide | 1件: Lanreotide acetate
Lanreotide acetate
💬
| 2件: SSTR2 SSTR2, SSTR5 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 4件: 67 67, 77, 85, 298 💬
|
57 | Lidocaine IV | 1件: Lidocaine Lidocaine | 3件: Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 298 298 💬
|
58 | Lipase | - | - | - | - | 2件: 298 298, 299 💬
|
59 | Liprotamase | - | - | - | - | 2件: 298 298, 299 💬
|
60 | LOW-intensity exercise therapy | - | - | - | - | 1件: 298 298 💬
|
61 | Lyrica | 1件: Pregabalin Pregabalin | 1件: Pregabalin
Pregabalin
💬
| 4件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬
| 7件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | 1件: 298 298 💬
|
62 | Magnesiocard 2.5mmol | - | - | - | - | 1件: 298 298 💬
|
63 | Magnesium | 1件: Magnesium Magnesium | - | - | - | 4件: 13 13, 46, 235, 298 💬
|
64 | Magnesium aspartate hydrochloride | 3件: Magnesium Magnesium, Magnesium aspartate, Magnesium aspartate hydrochloride | 1件: Magnesium L-aspartate
Magnesium L-aspartate
💬
| - | - | 1件: 298 298 💬
|
65 | Mayo interactive breath hold monitor | - | - | - | - | 2件: 298 298, 300 💬
|
66 | Mesenchymal stem cells | - | - | - | - | 17件: 2 2, 6, 13, 20, 46, 49, 50, 51, 60, 96, 97, 107, 222, 271, 274, 298, 299 💬
|
67 | Metamizole | 1件: Metamizole Metamizole | 3件: Dipyrone
Dipyrone
,
Metamizole
,
Dipyrone
💬
| - | - | 1件: 298 298 💬
|
68 | Metformin | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 23件: 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 84, 86, 97, 113, 127, 206, 218, 225, 265, 285, 298 💬
|
69 | Methionine | 1件: Methionine Methionine | 1件: Methionine
Methionine
💬
| - | - | 6件: 34 34, 75, 84, 94, 298, 300 💬
|
70 | Mezym F | - | - | - | - | 1件: 298 298 💬
|
71 | Midazolam | 1件: Midazolam Midazolam | 3件: Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 12件: 2 2, 3, 6, 13, 46, 67, 96, 97, 231, 272, 298, 299 💬
|
72 | Morphine | 1件: Morphine Morphine | 4件: Morphine sulfate
Morphine sulfate
,
Morphine hydrochloride hydrate
,
Morphine
,
Morphine tartrate
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 2件: 46 46, 298 💬
|
73 | MS1819 | - | - | - | - | 2件: 298 298, 299 💬
|
74 | MS1819-SD | 1件: MS-1819 MS-1819 | - | - | - | 2件: 298 298, 299 💬
|
75 | Namisol | - | - | - | - | 2件: 13 13, 298 💬
|
76 | NI-03 | - | - | - | - | 1件: 298 298 💬
|
77 | NO enzyme therapy | - | - | - | - | 1件: 298 298 💬
|
78 | NON-enteric coated pancreatic enzyme preparation | - | - | - | - | 1件: 298 298 💬
|
79 | Nutrition counseling | - | - | - | - | 1件: 298 298 💬
|
80 | Omeprazole | 1件: Omeprazole Omeprazole | 3件: Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 12件: 6 6, 13, 21, 46, 85, 90, 96, 97, 98, 271, 282, 298 💬
|
81 | Oxycodone | 1件: Oxycodone Oxycodone | 3件: Oxycodone hydrochloride
Oxycodone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 46 46, 298 💬
|
82 | Oxycodone depot ”sandoz”, depot tablets | 1件: Oxycodone Oxycodone | 3件: Oxycodone hydrochloride
Oxycodone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 298 298 💬
|
83 | Oxycodone hydrochloride | 1件: Oxycodone Oxycodone | 3件: Oxycodone hydrochloride
Oxycodone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 6 6, 70, 226, 298 💬
|
84 | Oxycodonhydrochlorid ”lannacher”, depot tablets | - | - | - | - | 1件: 298 298 💬
|
85 | Oxygen | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
💬
| - | - | 13件: 22 22, 49, 70, 85, 86, 88, 149, 168, 235, 271, 298, 299, 330 💬
|
86 | Oxynorm | - | - | - | - | 1件: 298 298 💬
|
87 | Pancreatic enzymes | - | - | - | - | 1件: 298 298 💬
|
88 | Pancreatin | 1件: Pancrelipase Pancrelipase | 2件: Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | 3件: 96 96, 298, 299 💬
|
89 | Pancrelipase | 2件: Pancrelipase Pancrelipase, Pancrelipase amylase | 2件: Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | 4件: 96 96, 97, 298, 299 💬
|
90 | Pancrelipase delayed release capsule | 1件: Pancrelipase Pancrelipase | 2件: Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | 2件: 298 298, 299 💬
|
91 | Pancrelipase/pancreas powder | 1件: Pancrelipase Pancrelipase | 2件: Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | 2件: 298 298, 299 💬
|
92 | Panzytrat | - | - | - | - | 1件: 298 298 💬
|
93 | Panzytrat 25.000 | - | - | - | - | 1件: 298 298 💬
|
94 | Panzytrat 25.000 FIP-E units OF lipase | - | - | - | - | 1件: 298 298 💬
|
95 | Paricalcitol | 1件: Paricalcitol Paricalcitol | 1件: Paricalcitol
Paricalcitol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 5件: 19 19, 66, 218, 238, 298 💬
|
96 | Pentoxifylline | 1件: Pentoxifylline Pentoxifylline | 1件: Pentoxifylline
Pentoxifylline
💬
| - | - | 11件: 26 26, 56, 84, 93, 96, 97, 113, 220, 222, 296, 298 💬
|
97 | Perflubutane | 1件: Perflubutane Perflubutane | 1件: Perflubutane
Perflubutane
💬
| - | - | 2件: 298 298, 300 💬
|
98 | Pethidine | 1件: Meperidine Meperidine | 2件: Meperidine hydrochloride
Meperidine hydrochloride
,
Pethidine
💬
| 1件: OPRM1 OPRM1 💬
| 5件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 2件: 97 97, 298 💬
|
99 | Pharmacologic approaches TO glycemic treatment | - | - | - | - | 1件: 298 298 💬
|
100 | Pinaverium bromide | 1件: Pinaverium Pinaverium | 1件: Pinaverium bromide
Pinaverium bromide
💬
| 1件: CACNA1S CACNA1S 💬
| 27件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Cardiac muscle contraction, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, GABAergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 298 298 💬
|
101 | Pioglitazone | 1件: Pioglitazone Pioglitazone | 2件: Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 16件: 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 220, 229, 265, 298, 299 💬
|
102 | PL 00512/0150 | - | - | - | - | 1件: 298 298 💬
|
103 | Pregabalin | 1件: Pregabalin Pregabalin | 1件: Pregabalin
Pregabalin
💬
| 4件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬
| 7件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | 5件: 13 13, 36, 46, 70, 298 💬
|
104 | Proglumide | 1件: Proglumide Proglumide | 1件: Proglumide
Proglumide
💬
| 1件: CCKBR CCKBR 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 298 298 💬
|
105 | Prolastin-C | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | 1件: alpha 1-Antitrypsin
alpha 1-Antitrypsin
💬
| 1件: SERPINA1 SERPINA1 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 231 231, 298 💬
|
106 | Proteolytic enzyme fortified protein supplement | - | - | - | - | 1件: 298 298 💬
|
107 | Quality-OF-life assessment | - | - | - | - | 11件: 28 28, 34, 36, 51, 62, 63, 65, 96, 284, 286, 298 💬
|
108 | Questionnaire administration | - | - | - | - | 7件: 16 16, 28, 34, 51, 60, 97, 298 💬
|
109 | Recombinant microbial lipase | - | - | - | - | 1件: 298 298 💬
|
110 | Recombinant microbial lipase SLV339 | - | - | - | - | 1件: 298 298 💬
|
111 | REGN475/SAR164877 | - | - | - | - | 1件: 298 298 💬
|
112 | Reparixin | 1件: Reparixin Reparixin | 1件: Reparixin
Reparixin
💬
| 2件: CXCR1 CXCR1, CXCR2 💬
| 7件: Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 298 298, 299 💬
|
113 | RVG 13760 | - | - | - | - | 1件: 298 298 💬
|
114 | S-ketamin | - | - | - | - | 1件: 298 298 💬
|
115 | SA-001 | - | - | - | - | 1件: 298 298 💬
|
116 | Secretin | 1件: Secretin human Secretin human | 1件: Secretin
Secretin
💬
| 1件: SCTR SCTR 💬
| 3件: Bile secretion Bile secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion 💬 | 1件: 298 298 💬
|
117 | Selenium | 1件: Selenium Selenium | - | - | - | 4件: 13 13, 96, 278, 298 💬
|
118 | Simvastatin | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 19件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 158, 160, 195, 265, 288, 298, 299, 310 💬
|
119 | SLV339 | - | - | - | - | 1件: 298 298 💬
|
120 | Smoking and alcohol assumption | - | - | - | - | 1件: 298 298 💬
|
121 | Sodium chloride 0.9% INJ | 1件: Sodium chloride Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬
| - | - | 1件: 298 298 💬
|
122 | Somatuline autogel 90 MG | 1件: Lanreotide Lanreotide | 1件: Lanreotide acetate
Lanreotide acetate
💬
| 2件: SSTR2 SSTR2, SSTR5 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 298 298 💬
|
123 | SOY bread | - | - | - | - | 1件: 298 298 💬
|
124 | Tanezumab | 1件: Tanezumab Tanezumab | 1件: Tanezumab
Tanezumab
💬
| 1件: NGFB NGFB 💬
| 9件: Apoptosis Apoptosis, Calcium signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 2件: 226 226, 298 💬
|
125 | Tetrahydro-6,6,9-TRI methyl-3-penthyl-6 H-dibenzo[ B,D ]pyran-1-OL | - | - | - | - | 1件: 298 298 💬
|
126 | Tetrahydrocannabinol | 1件: Dronabinol Dronabinol | 1件: Dronabinol
Dronabinol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 3件: 8 8, 13, 298 💬
|
127 | Thalidomide | 1件: Thalidomide Thalidomide | 1件: Thalidomide
Thalidomide
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300 💬
|
128 | Time interval between eswl and ercp IS 12H | - | - | - | - | 1件: 298 298 💬
|
129 | Time interval between eswl and ercp IS greater than 12H | - | - | - | - | 1件: 298 298 💬
|
130 | Tocilizumab | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 24件: 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
|
131 | Tocopherol | 1件: Tocopherol Tocopherol | 1件: Tocopherol
Tocopherol
💬
| - | - | 2件: 257 257, 298 💬
|
132 | Triamcinolone | 1件: Triamcinolone Triamcinolone | 4件: Triamcinolone
Triamcinolone
,
Triamcinolone acetonide
,
Triamcinolone diacetate
,
Triamcinolone hexacetonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 6件: 46 46, 53, 90, 96, 226, 298 💬
|
133 | TYR | - | - | - | - | 3件: 75 75, 77, 298 💬
|
134 | UVB | - | - | - | - | 1件: 298 298 💬
|
135 | Viokase 16 | - | - | - | - | 1件: 298 298 💬
|
136 | Viokase 16 (pancrelipase) + nexium | 1件: Esomeprazole Esomeprazole | 5件: Esomeprazole magnesium
Esomeprazole magnesium
,
Esomeprazole sodium
,
Esomeprazole
,
Esomeprazole strontium
,
Esomeprazole magnesium dihydrate
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 1件: 298 298 💬
|
137 | Viokase® 16 | - | - | - | - | 1件: 298 298 💬
|
138 | Vitamin D 100UG | 1件: Vitamin D Vitamin D | - | - | - | 1件: 298 298 💬
|
139 | Vitamin D 10UG | 1件: Vitamin D Vitamin D | - | - | - | 1件: 298 298 💬
|
140 | Yarrowia lipolytica lipase | - | - | - | - | 1件: 298 298 💬
|
141 | Zenpep | - | - | - | - | 2件: 298 298, 299 💬
|
142 | Zentase | - | - | - | - | 1件: 298 298 💬
|